]>
IRCT20190618043934N19 IRCT 2023-07-22 Birjand University of Medical Sciences The effect of chromium administration on the mean serum levels of HbA1C, FBS and 2hpp in diabetic patients The effect of chromium administration on mean serum levels of HbA1C, FBS and 2hpp in diabetic patients: A double-blind randomized controlled clinical trial 2023-07-22 anticipated 25 Complete https://irct.ir/trial/67853 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The placement of people in each group will be simple random and in a block method, in one of the two groups A (chromium picolinate tablets 200 mg twice a day after meals and with a full stomach for 3 months), the intervention B (take their routine diabetes medications and will be placed for 3 months). In this way, first, various blocks of four (AABB, BBAA, ABAB, BABA, ABBA and BABA) are created on different cards. One of these blocks will be randomly selected using the lottery method and the patients will be divided into one of two groups A or B. Then randomization is done for other patients as well. This will be done by the secretary, Blinding description: Outcome evaluator: The study leader (3rd year internal medicine assistant) and the laboratory expert, without knowing the type of drug received by the patients, takes the necessary samples and sends them to the laboratory for examination. 3 Diabetes. Intervention 1: Intervention group: First intervention group: Group A receiving chromium picolinate tablets 200 mg twice a day (after meals and on a full stomach) for 3 months. Intervention 2: Intervention group: The second intervention group: Group B receiving routine diabetes medications for 3 months. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no need to publish individual patient information
public Dr. Erfan Zeratkar
School of Medicine, Birjand University of medical sciences, Ghahhari Blvd, Birjand, South Khorasan, Iran.
Birjand Iran (Islamic Republic of) 9717934888 +98 56 3232 3232 oabstudent@gmail.com Birjand University of Medical Sciences scientific Dr. Anahita Aryan
School of Medicine, Birjand University of medical sciences, Ghahhari Blvd, Birjand, South Khorasan, Iran.
Birjand Iran (Islamic Republic of) 9717811674 +98 56 3232 3232 oabstudent@gmail.com Birjand University of Medical Sciences Iran (Islamic Republic of) Age over 40 years Patients with type 2 diabetes Having diabetes for at least 6 months Patients treated with oral medication Glycosylated hemoglobin below 9 40 years no limit Both Patients consuming minerals, vitamins or antioxidants or medicinal plants Pregnant or lactating women Heart failure disease Having another chronic disease Treatment of hyperlipidemia Having complications of diabetes including retinopathy, neuropathy and nephropathy Receive insulin Patients with kidney and liver failure Patients undergoing treatment for gastrointestinal diseases Thyroid problems, either hypo or hyperthyroid E08 Diabetes mellitus due to underlying condition Treatment - Drugs Treatment - Drugs Intervention group: First intervention group: Group A receiving chromium picolinate tablets 200 mg twice a day (after meals and on a full stomach) for 3 months. Intervention group: The second intervention group: Group B receiving routine diabetes medications for 3 months Fasting Blood Sugar. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: in serum samples of patients using the Bionic company kit. Glycosylated hemoglobin. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: in serum samples of patients using the Bionic company kit. Fasting blood sugar 2 hours after eating. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: in serum samples of patients using the Bionic company kit. Birjand University of Medical Sciences Approved 2022-09-05 Ethics Committee of Birjand University of Medical Sciences Vice Chancellor for Research and Technology, Birjand University of Medical Sciences, Ghaffari Blvd, Birjand, South Khorasan, Iran. Birjand South Khorasan Iran (Islamic Republic of)